Skip to main content

Introduction of shRNAs, miRNAs, or AntagomiRs into Primary Human Liver Cells Through Lentiviral Vectors

  • Protocol
  • First Online:
Lentiviral Vectors and Exosomes as Gene and Protein Delivery Tools

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1448))

Abstract

RNA interference (RNAi) is a specific and efficient method to silence gene expression in mammalian cells. However, genetic manipulation of primary cells including human hepatocytes by RNAi remained challenging. Therefore an efficient gene transfer protocol to modify gene expression in primary cells by using VSV-G-pseudotyped, EGFP-expressing lentiviral vectors was established. The protocol comprises the production of lentiviral vectors as well as the steps for efficient delivery of short-hairpin RNAs (shRNAs), microRNAs, or antagomiRs to human hepatocytes. With this method the amount of preparative work is reduced, by achieving high transduction efficiencies with low multiplicity of infection (MOI). Depending on the laboratory equipment, we provide two alternative workflows. The procedure of lentiviral vector production with subsequent titer determination takes approx. 6–10 working days.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Feidt DM, Klein K, Nussler A et al (2009) RNA-interference approach to study functions of NADPH: cytochrome P450 oxidoreductase in human hepatocytes. Chem Biodivers 6:2084–2091

    Article  CAS  PubMed  Google Scholar 

  2. Thomas M, Burk O, Klumpp B et al (2013) Direct transcriptional regulation of human hepatic cytochrome P450 3A4 by peroxisome proliferator-activated receptor alpha. Mol Pharmacol 83:709–718

    Article  CAS  PubMed  Google Scholar 

  3. Zanger UM, Klein K, Thomas M et al (2014) Genetics, epigenetics, and regulation of drug-metabolizing cytochrome p450 enzymes. Clin Pharmacol Ther 95:258–261

    Article  CAS  PubMed  Google Scholar 

  4. Burns JC, Friedmann T, Driever W et al (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci U S A 90:8033–8037

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ilan Y, Saito H, Thummala NR et al (1999) Adenovirus-mediated gene therapy of liver diseases. Semin Liver Dis 19:49–59

    Article  CAS  PubMed  Google Scholar 

  6. Jover R, Bort R, Gomez-Lechon MJ et al (2001) Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting. Hepatology 33:668–675

    Article  CAS  PubMed  Google Scholar 

  7. Oehmig A, Klotzbücher A, Thomas M et al (2008) A novel reverse transduction adenoviral array for the functional analysis of shRNA libraries. BMC Genomics 9:4411

    Article  Google Scholar 

  8. Zamule SM, Strom SC, Omiecinski CJ (2008) Preservation of hepatic phenotype in lentiviral-transduced primary human hepatocytes. Chem Biol Interact 173:179–186

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Godoy P, Hewitt NJ, Albrecht U et al (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 87(8):1315–1530

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Sastry L, Johnson T, Hobson MJ et al (2002) Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther 9:1155–1162

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The EGFP-expressing lentiviral vector pLenti6-GFP was kindly provided by Dr. Martin Kriebel, NMI, Reutlingen. We also thank Igor Liebermann and Britta Klumpp, Stuttgart, for expert technical assistance. This study was supported by the German Federal Ministry of Education and Research (Virtual Liver Network Grant 0315755) and by the Robert Bosch Foundation, Stuttgart, Germany.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Thomas .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this protocol

Cite this protocol

Rieger, J.K., Thomas, M. (2016). Introduction of shRNAs, miRNAs, or AntagomiRs into Primary Human Liver Cells Through Lentiviral Vectors. In: Federico, M. (eds) Lentiviral Vectors and Exosomes as Gene and Protein Delivery Tools. Methods in Molecular Biology, vol 1448. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3753-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3753-0_6

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-3751-6

  • Online ISBN: 978-1-4939-3753-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics